Insider Selling: Stryker (NYSE:SYK) VP Sells 5,220 Shares of Stock

Stryker Corporation (NYSE:SYK) VP M Kathryn Fink sold 5,220 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $283.85, for a total value of $1,481,697.00. Following the transaction, the vice president owned 13,137 shares in the company, valued at $3,728,937.45. The trade was a 28.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

M Kathryn Fink also recently made the following trade(s):

• On Monday, May 11th, M Kathryn Fink sold 3,500 shares of Stryker stock. The stock was sold at an average price of $283.45, for a total value of $992,075.00.

Stryker Trading Up 4.3%

SYK traded up $12.16 during trading on Tuesday, hitting $294.74. 3,287,824 shares of the stock were exchanged, compared to its average volume of 2,151,943. The firm has a 50 day simple moving average of $336.33 and a 200 day simple moving average of $353.81. The firm has a market cap of $112.88 billion, a price-to-earnings ratio of 34.11, a P/E/G ratio of 1.80 and a beta of 0.80. Stryker Corporation has a 1 year low of $281.00 and a 1 year high of $404.87. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by ($0.38). The firm had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, equities analysts expect that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.2%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio (DPR) is presently 40.74%.

Analysts Set New Price Targets

Several research analysts have commented on SYK shares. Truist Financial restated a “hold” rating and set a $330.00 price objective (down from $380.00) on shares of Stryker in a report on Monday, May 4th. Wells Fargo & Company cut their price target on Stryker from $456.00 to $418.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. TD Cowen downgraded Stryker from a “buy” rating to a “hold” rating and set a $387.00 price target on the stock. in a report on Monday, January 26th. BTIG Research cut their price target on Stryker from $397.00 to $379.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Finally, William Blair reiterated an “outperform” rating on shares of Stryker in a report on Thursday, March 5th. Sixteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $395.48.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in SYK. Godfrey Financial Associates Inc. purchased a new position in shares of Stryker in the 4th quarter valued at $26,000. Sankala Group LLC acquired a new stake in shares of Stryker in the 4th quarter worth $26,000. United Financial Planning Group LLC acquired a new stake in shares of Stryker in the 3rd quarter worth $27,000. Atlas Capital Advisors Inc. acquired a new stake in shares of Stryker in the 4th quarter worth $27,000. Finally, DJE Kapital AG acquired a new stake in shares of Stryker in the 4th quarter worth $28,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.